standard of care
Since its foundation, Debiopharm has been driven by the same commitment: to provide innovative solutions to patients in order to improve their quality of life
Debiopharm was founded in 1979 by Dr. Rolland-Yves Mauvernay. The company is dedicated to in-licensing innovative compounds for development into drugs for commercialization through international partnerships.
Today Debiopharm is a group of three companies active in drug development in oncology and bacterial infections (Debiopharm International), drug manufacturing (Debiopharm Research & Manufacturing) and investment in digital health (Debiopharm Innovation Fund).